The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells

被引:248
作者
Loser, Karin [1 ,2 ]
Vogl, Thomas [2 ,3 ]
Voskort, Maik [1 ]
Lueken, Aloys [3 ]
Kupas, Verena [1 ]
Nacken, Wolfgang [4 ]
Klenner, Lars [1 ]
Kuhn, Annegret [1 ]
Foell, Dirk [3 ]
Sorokin, Lydia [5 ]
Luger, Thomas A. [1 ,2 ]
Roth, Johannes [2 ,3 ]
Beissert, Stefan [1 ,2 ]
机构
[1] Univ Munster, Dept Dermatol, D-4400 Munster, Germany
[2] Univ Munster, Interdisciplinary Ctr Clin Res, D-4400 Munster, Germany
[3] Univ Munster, Inst Immunol, D-4400 Munster, Germany
[4] Univ Munster, Inst Mol Virol, D-4400 Munster, Germany
[5] Univ Munster, Inst Pathobiochem, D-4400 Munster, Germany
关键词
CUTANEOUS LUPUS-ERYTHEMATOSUS; CD40; LIGAND; S100; PROTEINS; SYSTEMIC AUTOIMMUNITY; DENDRITIC CELLS; IN-VITRO; ARTHRITIS; DISEASE; SKIN; EXPRESSION;
D O I
10.1038/nm.2150
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mechanisms linking innate immunity and autoimmune responses are poorly understood(1). Myeloid-related protein-8 (Mrp8) and Mrp14 are damage-associated molecular pattern molecules (DAMPs) highly upregulated in various autoimmune disorders. We show in a mouse autoimmune model that local Mrp8 and Mrp14 production is essential for the induction of autoreactive CD8(+) T cells and the development of systemic autoimmunity. This effect is mediated via Toll-like receptor 4 (TLR4) signaling leading to increased interleukin-17 (IL-17) expression. Notably, expression of Mrp8 and Mrp14 was upregulated in cutaneous lupus erythematosus, and stimulation of CD8(+) T cells from individuals with lupus erythematosus with MRP proteins resulted in an upregulation of IL-17, suggesting a key role for MRP8 and MRP14 for the development of autoreactive lymphocytes during human autoimmunity as well. These results demonstrate a link between local expression of DAMP molecules and the development of systemic autoimmunity.
引用
收藏
页码:713 / U119
页数:6
相关论文
共 29 条
[1]   Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosis [J].
Bogumil, T ;
Rieckmann, P ;
Kubuschok, B ;
Felgenhauer, K ;
Brück, W .
NEUROSCIENCE LETTERS, 1998, 247 (2-3) :195-197
[2]   S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products [J].
Boyd, John H. ;
Kan, Bernard ;
Roberts, Haley ;
Wang, Yingjin ;
Walley, Keith R. .
CIRCULATION RESEARCH, 2008, 102 (10) :1239-1246
[3]   S100 protein subcellular localization during epidermal differentiation and psoriasis [J].
Broome, AM ;
Ryan, D ;
Eckert, RL .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2003, 51 (05) :675-685
[4]  
Caproni M, 2007, J RHEUMATOL, V34, P2412
[5]   The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer [J].
Ehrchen, Jan M. ;
Sunderkoetter, Cord ;
Foell, Dirk ;
Vogl, Thomas ;
Roth, Johannes .
JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 86 (03) :557-566
[6]   Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease [J].
Foell, D. ;
Wittkowski, H. ;
Ren, Z. ;
Turton, J. ;
Pang, G. ;
Daebritz, J. ;
Ehrchen, J. ;
Heidemann, J. ;
Borody, T. ;
Roth, J. ;
Clancy, R. .
JOURNAL OF PATHOLOGY, 2008, 216 (02) :183-192
[7]   Proinflammatory S100 proteins in arthritis and autoimmune disease [J].
Foell, D ;
Roth, J .
ARTHRITIS AND RHEUMATISM, 2004, 50 (12) :3762-3771
[8]   CD40 and CD154 in cell-mediated immunity [J].
Grewal, IS ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :111-135
[9]   Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis [J].
Grewal, IS ;
Foellmer, HG ;
Grewal, KD ;
Xu, JC ;
Hardardottir, F ;
Baron, JL ;
Janeway, CA ;
Flavell, RA .
SCIENCE, 1996, 273 (5283) :1864-1867
[10]   Two-step negative enrichment of CD4+ and CD8+ T cells from murine spleen via nylon wool adherence and an optimized antibody cocktail [J].
Gunzer, M ;
Weishaupt, C ;
Planelles, L ;
Grabbe, S .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 258 (1-2) :55-63